Genetic Alterations in the Retinoblastoma Protein-Related p107 Gene in Human Hematologic Malignancies
- 9 October 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 251 (1), 264-268
- https://doi.org/10.1006/bbrc.1998.9459
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 19 references indexed in Scilit:
- Binding and Suppression of the Myc Transcriptional Activation Domain by p107Science, 1994
- Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.Genes & Development, 1993
- Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.Genes & Development, 1992
- The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated mannerCell, 1992
- Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related proteinCell, 1991
- An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 and a second cellular protein, p120Cell, 1989
- The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virusCell, 1989
- Cellular targets for transformation by the adenovirus E1A proteinsCell, 1989
- Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene productNature, 1988
- SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility geneCell, 1988